VEGFA and age-related macular degeneration: During 5-year follow-up, three RPD patients did not develop late-stage AMD, one patient developed perifoveal GA (cRORA), and four had to be treated with 9.25 ± 4.9 anti-VEGF injections due to foveal MNV development.